Safety and Efficacy of Tocilizumab in Patients With Myelin Oligodendrocyte Glycoprotein Antibody-associated Disease
Clinical trial NCT06452537 · ACTIVE_NOT_RECRUITING
Trial details
- NCT number
- NCT06452537
- Sponsor
- Tianjin Medical University General Hospital
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- Phase 2, Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2024-07-09
- Primary completion
- 2026-01-01
- Enrollment
- 102
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.